Approach Considerations, Treatment of Invasive Breast Cancer, Systemic Adjuvant Therapy for Breast Cancer. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet- Tieulent J, Jemal A. Global cancer statistics, 2. CA Cancer J Clin. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2. CA Cancer J Clin. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 1. 9(5): 1. Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheets: Breast. Available at http: //seer. Accessed: July 3. Jatoi I, Anderson WF, Rosenberg PS. Qualitative age- interactions in breast cancer: a tale of two diseases? Am J Clin Oncol. 3. Parmigiani G, Chen S, Iversen ES Jr, Friebel TM, Finkelstein DM, Anton- Culver H, et al. Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med. 1. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Dec 1. 5. 1. 04(1. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Only Answer to Cancer. ONLY ANSWER TO CANCER. Excerpt from Dr. Leonard Coldwell’s Books: “The Only Answer to Cancer”(revised) & How I cured my mother of liver. Hershman is Leader of the Breast Cancer Program of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the. Ben Skywalker was a Human male Jedi Knight from Coruscant, active mostly during the Second. Zambian Cancer Resources Latest Research Publications related to Zambia Zambian Cancer Resources (5 links) Center for Infectious Disease Research in Zambia. Original Article. Mechanical Ventilation Guided by Esophageal Pressure in Acute Lung Injury. Daniel Talmor, M.D., M.P.H., Todd Sarge, M.D., Atul Malhotra, M.D., Carl. Annu Rev Public Health. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 7. Nurses' Health Study. Am J Epidemiol. 2. Nov 1. 5. 1. 52(1. Deligeoroglou E, Michailidis E, Creatsas G. Oral contraceptives and reproductive system cancer. Ann N Y Acad Sci. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Hormonal factors and the risk of invasive ovarian cancer: a population- based case- control study. Fertil Steril. 8. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. Hankinson SE, Eliassen AH. Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer. Preventive therapy for breast cancer: a consensus statement. Lancet Oncol. 1. 2(5): 4. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P- 1 study. I have been diagnoised w/ ovarian stage three cancer in Feb. I have finished my treatments in June. My ca125 level has gone back up to 30.I have started taking. Before viewing my diet suggestions, please understand that health begins with what you eliminate from your diet, not with what you add. The first step in recovery and. Clinical Guidelines. Authored by a talented group of GI experts, the College is devoted to the development of new ACG guidelines on gastrointestinal and liver diseases. J Natl Cancer Inst. Nov 1. 6. 9. 7(2. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P- 1 Study. J Natl Cancer Inst. Sep 1. 6. 9. 0(1. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P- 2 trial. Jun 2. 1. 2. 95(2. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. Apr 1. 7. 9. 4(8): 6. Santen RJ, Boyd NF, Chlebowski RT, Cummings S, Cuzick J, Dowsett M, et al. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer. Endogenous Hormones and Breast Cancer Collaborative Group. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. Cancer Epidemiol Biomarkers Prev. Marchbanks PA, Mc. Donald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2. 00. Jun 2. 7. 3. 46(2. Garbe E, Levesque L, Suissa S. Variability of breast cancer risk in observational studies of hormone replacement therapy: a meta- regression analysis. Mar 1. 5. 4. 7(3): 1. Reeves GK, Beral V, Green J, Gathani T, Bull D. Hormonal therapy for menopause and breast- cancer risk by histological type: a cohort study and meta- analysis. Lancet Oncol. 7(1. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen- progestin replacement therapy and breast cancer risk. Jan 2. 6. 2. 83(4): 4. Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow- up of the Women's Health Initiative randomised placebo- controlled trial. Lancet Oncol. 1. 3(5): 4. The Million Women Study and breast cancer. Sep 2. 5. Holmberg L, Anderson H. HABITS (hormonal replacement therapy after breast cancer- -is it safe?), a randomised comparison: trial stopped. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med. 1. 99. Aug 1. 1. 3. 31(6): 3. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence- based review. Page DL, Jensen RA. Evaluation and management of high risk and premalignant lesions of the breast. World J Surg. 1. 99. Jan- Feb. Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Jan 1. 1. 3. 61(9. Breast lesions, pathology and cancer risk. Jan- Feb. 1. 0 Suppl 1: S3- 4. Ashbeck EL, Rosenberg RD, Stauber PM, Key CR. Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2. 5(1. Dupont WD, Page DL, Parl FF, Vnencak- Jones CL, Plummer WD Jr, Rados MS, et al. Long- term risk of breast cancer in women with fibroadenoma. N Engl J Med. 3. 31(1): 1. Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat. Suppl 1: S1. 1- 7. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control. Breast cancer and the western diet: role of fatty acids and antioxidant vitamins. Eur J Cancer. 3. 4(1. Holmes MD, Liu S, Hankinson SE, Colditz GA, Hunter DJ, Willett WC. Dietary carbohydrates, fiber, and breast cancer risk. Am J Epidemiol. 2. Apr 1. 5. 1. 59(8): 7. Holmes MD, Willett WC. Does diet affect breast cancer risk? Breast Cancer Res. Medscape Medical News. Available at http: //www. March 0. 8, 2. 01. Accessed: March 1. Brandt PA, Schulpen M. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta- analysis. Int J Cancer. Adult weight change and risk of postmenopausal breast cancer. Jul 1. 2. 2. 96(2): 1. Han D, Nie J, Bonner MR, Mc. Cann SE, Muti P, Trevisan M, et al. Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study. Int J Cancer. 2. 00. Dec 1. 5. 1. 19(1. Nutrition, insulin, IGF- 1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp. Lukanova A, Lundin E, Zeleniuch- Jacquotte A, Muti P, Mure A, Rinaldi S, et al. Body mass index, circulating levels of sex- steroid hormones, IGF- I and IGF- binding protein- 3: a cross- sectional study in healthy women. Eur J Endocrinol. Baer HJ, Colditz GA, Rosner B, Michels KB, Rich- Edwards JW, Hunter DJ, et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res. R3. 14- 2. 5. Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer. Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk. Environmental risk factors and female breast cancer. Annu Rev Public Health. The effect of environment on breast cancer risk. Breast Cancer Res Treat. Gammon MD, Eng SM, Teitelbaum SL, Britton JA, Kabat GC, Hatch M, et al. Environmental tobacco smoke and breast cancer incidence. Environ Res. 9. 6(2): 1. Smith- Bindman R. Environmental causes of breast cancer and radiation from medical imaging: findings from the Institute of Medicine report. Arch Intern Med. 1. Carmichael A, Sami AS, Dixon JM. Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. Eur J Surg Oncol. Clemons M, Loijens L, Goss P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev. Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Nov 1. 5. 1. 06(1. Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1. Cancer Epidemiol Biomarkers Prev. American Cancer Society. Breast Cancer Facts & Figures 2. Available at https: //www. Accessed: January 3. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. Breast cancer incidence, 1. J Natl Cancer Inst. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U. S. Breast Cancer Res. The decrease in breast- cancer incidence in 2. United States. N Engl J Med. Apr 1. 9. 3. 56(1. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. Breast cancer and hormone- replacement therapy in the Million Women Study. Anderson WF, Reiner AS, Matsuno RK, Pfeiffer RM. Shifting breast cancer trends in the United States. J Clin Oncol. 2. 5(2. Evidence- based assessment of the impact of the WHI on women’s health. Burger HG, Mac. Lennan AH, Huang KE, Castelo- Branco C. Climacteric. 1. 5(3): 2. Breast Cancer. Version 1. National Comprehensive Cancer Network. Available at http: //www. March 1. 0, 2. 01. Accessed: April 5, 2. Baselga J, Seidman AD, Rosen PP, Norton L.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2017
Categories |